Cipla Limited -1.21 % Drug Manufacturers - Major

Trend Analysis


Support and Resistance Levels Analysis
The current close value 526.8 is between the support and resistance channel of 521 and 530. The stock has a Sell Signal , 521 becomes a critical support to stop the fall and 530 is a immediate resistance on the upside.

Technical Indicators (3 Month duration)
Exponential Moving average 531.7
MACD value 0.9
Price range 492.15 to 554.55
Volume range 1406199 to 3910415
Support & Resistance 521, 530
Stock Performance
Six Months -17.3%
Five Months-13.2%
Four Months-2.6%
Three Months0.9%
Two Months3.8%
One Month-2.7%
Last Six Months


Last Five Months


Last Four Months


Last Three Months


Last Two Months


Last One Month


Today's Price Range
3 Month Price Range
About Cipla Limited
Cipla Limited (Cipla) is an India-based global pharmaceutical company. The Company's portfolio includes approximately 2000 products in 65 therapeutic categories with one quality standard globally. Cipla's turnover in 2012/13 was approximately 1.5 billion USD. The Company's research and development focus on developing products and drug delivery systems for different formulations. Africa contributes 25% of overall revenues, a testament to its focus on ensuring affordable access to patients across the world. As the Company that showed the way in manufacturing active pharmaceutical ingredients in India, Cipla has expanded its portfolio to approximately 200 products. The Company offers approximately 65 different inhaled products and has a range of inhaled medications and devices. Across markets, Cipla offers metered dose inhalers (pMDIs) with dose indicators, innovative dry powder inhalers, nasal sprays, nebulisers, non-electrostatic spacers, and infant and baby masks.
See stocks similar to Cipla Limited in Drug Manufacturers - Major

Cipla Limited has Sell Signal. What is your opinion on it?

{ }